J. Siekmann

415 total citations
12 papers, 342 citations indexed

About

J. Siekmann is a scholar working on Hematology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. Siekmann has authored 12 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 3 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. Siekmann's work include Platelet Disorders and Treatments (5 papers), Hemophilia Treatment and Research (5 papers) and Blood transfusion and management (3 papers). J. Siekmann is often cited by papers focused on Platelet Disorders and Treatments (5 papers), Hemophilia Treatment and Research (5 papers) and Blood transfusion and management (3 papers). J. Siekmann collaborates with scholars based in Austria, United States and Canada. J. Siekmann's co-authors include Peter L. Turecek, M.J. Bossard, Katalin Váradi, Margaret L. Rand, Manuel Carção, A. M. Stain, Cathy Sparling, Victor S. Blanchette, David Lillicrap and P. L. Turecek and has published in prestigious journals such as Blood, Thrombosis and Haemostasis and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

J. Siekmann

12 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Siekmann Austria 7 276 53 50 48 36 12 342
R Rawala-Sheikh United States 10 373 1.4× 24 0.5× 165 3.3× 21 0.4× 20 0.6× 11 411
K Yamazumi Japan 13 120 0.4× 61 1.2× 8 0.2× 56 1.2× 13 0.4× 19 438
Lin‐Pierre Zhao France 7 74 0.3× 29 0.5× 63 1.3× 14 0.3× 28 0.8× 25 178
M Hrubisko Slovakia 7 102 0.4× 61 1.2× 39 0.8× 37 0.8× 8 0.2× 25 276
E J Tunn United Kingdom 10 82 0.3× 25 0.5× 45 0.9× 14 0.3× 66 1.8× 11 377
Lorenza Borin Italy 8 154 0.6× 42 0.8× 84 1.7× 9 0.2× 19 0.5× 22 231
Matthias Freund Germany 5 103 0.4× 44 0.8× 37 0.7× 7 0.1× 77 2.1× 6 197
Francesca Fazio Italy 7 52 0.2× 61 1.2× 23 0.5× 11 0.2× 23 0.6× 32 148
Ana Karen Nunez Cortes Mexico 7 41 0.1× 26 0.5× 31 0.6× 9 0.2× 22 0.6× 12 121
Jessica MacLean Canada 7 43 0.2× 61 1.2× 7 0.1× 25 0.5× 8 0.2× 10 167

Countries citing papers authored by J. Siekmann

Since Specialization
Citations

This map shows the geographic impact of J. Siekmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Siekmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Siekmann more than expected).

Fields of papers citing papers by J. Siekmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Siekmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Siekmann. The network helps show where J. Siekmann may publish in the future.

Co-authorship network of co-authors of J. Siekmann

This figure shows the co-authorship network connecting the top 25 collaborators of J. Siekmann. A scholar is included among the top collaborators of J. Siekmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Siekmann. J. Siekmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Turecek, Peter L., J. Siekmann, Artur Mitterer, et al.. (2015). Development of BAX 826, a Polysialylated Full-Length rFVIII with Significantly Improved PK Properties. Blood. 126(23). 3536–3536. 3 indexed citations
2.
3.
Turecek, Peter L., M.J. Bossard, Michael Graninger, et al.. (2012). BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.. PubMed. 32 Suppl 1. S29–38. 86 indexed citations
4.
Stidl, Reinhard, J. Siekmann, Tony Vinson, et al.. (2011). Absorption, Metabolism, Distribution, and Excretion of Longer Acting rFVIII (BAX 855) Following Intravenous Administration to Rats. Blood. 118(21). 4358–4358. 1 indexed citations
5.
Marchetti‐Deschmann, Martina, et al.. (2010). GEMMA and MALDI-TOF MS of reactive PEGs for pharmaceutical applications. Journal of Pharmaceutical and Biomedical Analysis. 52(4). 432–437. 19 indexed citations
6.
Turecek, Peter L., Artur Mitterer, Herbert Gritsch, et al.. (2009). Development of a plasma- and albumin -free recombinant von Willebrand factor. Hämostaseologie. 29(S 01). S32–S38. 49 indexed citations
7.
Turecek, Peter L., Friedrich Scheiflinger, J. Siekmann, et al.. (2006). Biochemical and Functional Characterization of PEGylated rVWF.. Blood. 108(11). 1021–1021. 6 indexed citations
8.
Turecek, Peter L., J. Siekmann, Alfred Weber, et al.. (2006). Modification of rVWF with Polysialic Acid: Biochemical and Functional Characterization in Mice with VWD.. Blood. 108(11). 1001–1001. 3 indexed citations
9.
10.
Auerswald, Günter, Werner Engl, W. Kreuz, et al.. (2002). A high‐purity double virus inactivated FVIII/vWF concentrate (Immunate) in the successful treatment of patients with von Willebrand disease. Haemophilia. 8(6). 836–836. 1 indexed citations
11.
Blanchette, Victor S., Manuel Carção, A. M. Stain, et al.. (2000). von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.. PubMed. 84(3). 401–9. 93 indexed citations
12.
Váradi, Katalin, J. Siekmann, Peter L. Turecek, HP Schwarz, & VJ Marder. (1999). Phospholipid-bound Tissue Factor Modulates both Thrombin Generation and APC-mediated Factor Va Inactivation. Thrombosis and Haemostasis. 82(12). 1673–1679. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Rawala-Sheikh Breakdown of academic impact, for papers by K Yamazumi Breakdown of academic impact, for papers by Lin‐Pierre Zhao Breakdown of academic impact, for papers by M Hrubisko Breakdown of academic impact, for papers by E J Tunn Breakdown of academic impact, for papers by Lorenza Borin Breakdown of academic impact, for papers by Matthias Freund Breakdown of academic impact, for papers by Francesca Fazio Breakdown of academic impact, for papers by Ana Karen Nunez Cortes Breakdown of academic impact, for papers by Jessica MacLean
Rankless by CCL
2026